scholarly journals Aortic valve replacement due to aortic valve stenosis at the Department of Cardiothoracic Surgery in University Hospital Centre Osijek from 2007 to 2016

2016 ◽  
Vol 11 (12) ◽  
pp. 623-624
Author(s):  
Iva Jurić ◽  
Hrvoje Roguljić ◽  
Marko Stupin ◽  
Ana Srnović ◽  
Grgur Dulić ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Aortic Valve Stenosis ◽  
Cardiothoracic Surgery ◽  
University Hospital

EVALUATION OF THE RESULT OF SUTURELESS AORTIC VALVE REPLACEMENT

2019 ◽  
pp. 44-50
Author(s):  
Duc An Vinh Bui ◽  
Hoang Nam Nguyen ◽  
Ba Phong Nguyen ◽  
Adama Sawadogo ◽  
Kasra Azarnoush
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Aortic Valve Stenosis ◽  
University Hospital ◽  
Western World ◽  
Replacement Technique ◽  
Risk Patients ◽  
Valve Pathology

Background: Aortic valve stenosis is the most frequent cardiac valve pathology in the western world. In the last few years, sutureless valves have been strongly developed with a lot of applications. The aim of this study was to evaluate the feasibility, mid-term outcomes of sutureless aortic valve replacement technique. Subjects and methods: 13 patients who underwent sutureless aortic valve replacement between 12/2015 to 05/2018 at Clermont – Ferrand University Hospital, France. Descriptive study, postoperative follow-up, clinical evaluation, and echocardiography. Results: mean cross-clamp time was 84.8 ± 22.9 min, mean cardiopulmonary bypass time was 113.4 ± 21.2 min. Improved mean preoperative and postoperative aortic gradients: 40.3 ± 17.4 mmHg versus 10.5 ± 4.8 mmHg (1 month) and 12.0 ± 4.5 mmHg (6 months). Mean intensive care unit stay was 7.8 ± 11.8 days, mean hospital stay was 23.2 ± 15.5 days. No case of death was reported after 6 months. Conclusion: sutureless aortic valve replacement technique is feasible, with good short-term and mid-term outcomes, improve hemodynamics, can be applied in intermediate and high-risk patients. Key words: aortic valve stenosis, aortic valve replacement, sutureless aortic valve

A case of adult unicuspid aortic valve stenosis that underwent emergent aortic valve replacement for severe heart failure

Choonpa Igaku ◽  
2020 ◽  
Vol 47 (5) ◽  
pp. 191-195
Author(s):  
Masayuki YAMASAKI ◽  
Yoshio TAKEUCHI ◽  
Keitaro NAKAGIRI ◽  
Rie TAKAOKA ◽  
Kimika YOSHINAGA ◽  
...  
Keyword(s):  
Heart Failure ◽  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Aortic Valve Stenosis ◽  
Severe Heart Failure

Use and outcomes of emergency treatment strategies in patients with aortic valve stenosis

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
S.M Piepenburg ◽  
K Kaier ◽  
C Olivier ◽  
M Zehender ◽  
C Bode ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Hospital Mortality ◽  
Valve Replacement ◽  
Aortic Valve Stenosis ◽  
Emergency Treatment ◽  
Funding Source ◽  
Artery Disease

Abstract Introduction and aim Current emergency treatment options for severe aortic valve stenosis include surgical aortic valve replacement (SAVR), transcatheter aortic valve replacement (TAVR) and balloon valvuloplasty (BV). So far no larger patient population has been evaluated regarding clinical characteristics and outcomes. Therefore we aimed to describe the use and outcome of the three therapy options in a broad registry study. Method and results Using German nationwide electronic health records, we evaluated emergency admissions of symptomatic patients with severe aortic valve stenosis between 2014 and 2017. Patients were grouped according to SAVR, TAVR or BV only treatments. Primary outcome was in-hospital mortality. Secondary outcomes were stroke, acute kidney injury, periprocedural pacemaker implantation, delirium and prolonged mechanical ventilation >48 hours. Stepwise multivariable logistic regression analyses including baseline characteristics were performed to assess outcome risks. 8,651 patients with emergency admission for severe aortic valve stenosis were identified. The median age was 79 years and comorbidities included NYHA classes III-IV (52%), coronary artery disease (50%), atrial fibrillation (41%) and diabetes mellitus (33%). Overall in-hospital mortality was 6.2% during a mean length of stay of 22±15 days. TAVR was the most common treatment (6,357 [73.5%]), followed by SAVR (1,557 [18%]) and BV (737 8.5%]). Patients who were treated with TAVR or BV were significantly older than patients with SAVR (mean age 81.3±6.5 and 81.2±6.9 versus 67.2±11.0 years, p<0.001), had more relevant comorbidities (coronary artery disease 52–91% vs. 21.8%; p<0.001), worse NYHA classes III-IV (55–65% vs. 34.5%; p<0.001) and higher EuroSCORES (24.6±14.3 and 23.4±13.9 vs. 9.5±7.6; p<0.001) than SAVR patients. Patients treated with BV only had the highest in-hospital mortality compared with TAVR or SAVR (20.9% vs. 5.1 and 3.5%; p<0.001). Compared with BV only, SAVR patients (adjusted odds ratio [aOR] 0.25; 95% confidence interval [CI] 0.14–0.46; p<0.001) and TAVR patients (aOR 0.37; 95% CI 0.28–0.50; p<0.001) had a lower risk for in-hospital mortality. Conclusion In-hospital mortality for emergency patients with symptomatic severe aortic valve stenosis is high. Our results showed that BV only therapy was associated with highest mortality, which is in line with current research. Yet, there is a trend towards more TAVR interventions and this study might imply that balloon valvuloplasty alone is insufficient. The role of BV as a bridging strategy to TAVR or SAVR needs to be further investigated. Funding Acknowledgement Type of funding source: Public hospital(s). Main funding source(s): Heart Center Freiburg University, Department of Cardiology and Angiology I, Faculty of Medicine, University of Freiburg, Freiburg, Germany

Prevention of atrial fibrillation in patients with aortic valve stenosis with candesartan treatment after aortic valve replacement

2013 ◽  
Vol 165 (2) ◽  
pp. 242-246 ◽  
Author(s):  
Jordi S. Dahl ◽  
Lars Videbæk ◽  
Mikael K. Poulsen ◽  
Patricia A. Pellikka ◽  
Karsten Veien ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Aortic Valve Stenosis
Sign in / Sign up

Export Citation Format

Share Document